Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
964.7 USD | -0.17% | -0.33% | +9.85% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 25 | Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.85% | 104B | |
+3.33% | 108B | |
+6.43% | 23.66B | |
-11.69% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.21% | 16.19B | |
+5.01% | 13.72B | |
+34.86% | 12.22B | |
-6.50% | 10.36B |
- Stock
- Equities
- Stock Regeneron Pharmaceuticals, Inc. - Nasdaq
- News Regeneron Pharmaceuticals, Inc.
- Insider Sell: Regeneron Pharmaceuticals